Nicotine crosses the lining of your mouth by slipping through cell membranes in its uncharged, “free-base” form, driven largely by the pH of the environment around it. When conditions are alkaline enough, nicotine sheds its positive charge and becomes fat-soluble, which lets it pass through the lipid-rich walls of oral tissue cells and enter nearby blood vessels. From there it travels directly into general circulation, skipping the liver and the heavy metabolism that swallowed nicotine would face. The process is slower than inhaling smoke but, depending on the product, can ultimately deliver comparable or even greater amounts of nicotine into the bloodstream.
Why pH Is the Master Switch
Nicotine is a weak base with two sites that can pick up a hydrogen ion. At acidic pH, both sites tend to be protonated, giving the molecule a positive charge. Charged molecules do not cross fatty cell membranes easily. As the environment becomes more alkaline and climbs above roughly pH 8, nicotine increasingly exists in its uncharged, free-base state. Free-base nicotine has a much stronger affinity for the phospholipid layers that make up cell surfaces, so it moves through oral tissue far more readily.1ACS Omega. Evaluation of Factors Impacting Nicotine Permeation in Oral Nicotine Pouch Products Laboratory permeation studies have confirmed that the neutral nicotine species has higher permeability than the ionized form, owing to both a better partition coefficient and faster diffusion.2PubMed. A mechanistic analysis to characterize oramucosal permeation properties
This is exactly why smokeless tobacco products have long been formulated with alkaline additives. Traditional snuff, for instance, is buffered to a pH of 8 to 9 by adding sodium carbonate, specifically because nicotine absorption through the mucous membrane is directly proportional to pH.3PubMed Central. Is Sodium Carbonate in Snuff a Causative Factor for Oral Mucosal Lesions Modern tobacco-free nicotine pouches use similar strategies. Some use calcium sulphate granules that create a higher local pH, resulting in faster initial nicotine release and uptake compared to products that rely on a more slowly dissolving nicotine salt form.4Discover Medicine. Comparative study of calcium sulphate and cellulose based nicotine pouch on pharmacokinetics, pulse rate and nicotine extraction The chemistry is the same principle every time: push pH up, shift nicotine into its free-base form, and absorption speeds up.
Where in the Mouth Absorption Happens Best
Not all oral tissue is equally permeable. The inside of your mouth is lined by a mucosa that varies in thickness and structure from region to region. Some areas, like the hard palate and the gums attached to bone, are covered by a tougher, keratinized layer similar in principle to the outer layer of your skin. Other areas, such as the floor of the mouth (sublingual area) and the inner cheek (buccal mucosa), are thinner and less keratinized. Research on drug absorption across different oral regions has shown that the thickness of the outermost barrier layer is the principal obstacle: the thicker it is, the less drug gets through.5PubMed. Regional variation in oral mucosal drug absorption: permeability and degree of keratinization in hamster oral cavity
In practice, most nicotine pouches and snus are placed between the upper lip and the gum. This spot offers a combination of relatively thin tissue, good contact with the product, and proximity to blood vessels.6Nature. A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products Nicotine gum and lozenges, meanwhile, are typically worked around the cheek and tongue areas, relying on the buccal and sublingual mucosa. The sublingual region is often considered the most permeable part of the mouth, which is why certain pharmaceutical tablets are designed to dissolve there. But for nicotine products that sit in place for extended periods, the upper lip area works well because it keeps the product stationary and in sustained contact with the tissue.
Bypassing the Liver
One of the key advantages of oral mucosal absorption, from a pharmacological standpoint, is that nicotine entering through the mouth lining goes directly into the venous blood of the head and neck and then into general circulation. When you swallow nicotine instead, it travels to the stomach and intestines, gets absorbed into the portal vein, and is routed through the liver before reaching the rest of the body. The liver metabolizes a substantial fraction of nicotine on this first pass, converting it into cotinine and other metabolites. This “first-pass effect” means swallowed nicotine is far less efficient at reaching the brain.
Studies of nicotine gum have shown that when users swallow too much saliva while chewing, the ratio of nicotine metabolites to parent nicotine rises disproportionately compared to smoking, indicating that a portion of the nicotine was swallowed and subjected to first-pass metabolism in the liver. The balance between buccal absorption and swallowing turns out to be an important factor in how much nicotine actually makes it into circulation.7PubMed. Determinants of nicotine intake while chewing nicotine polacrilex gum With modern nicotine pouches, one clinical study found that only about 1.8% of the nicotine in a reference pouch was detected in saliva collected over a 30-minute use period, suggesting that very little nicotine was being swallowed during use.8PubMed Central. A Randomized Crossover Clinical Study to Assess the Effect of Oral Nicotine Pouches Used for Different Durations on Plasma Nicotine Pharmacokinetics in Healthy Oral Pouch Consumers That said, some researchers have raised concerns that nicotine dissolved in saliva is likely to be swallowed to some degree, potentially irritating the digestive tract.9Current Research in Toxicology. Research on the safety risk of oral nicotine products and its prospects
How Fast and How Much Compared to Smoking
Smoking a cigarette delivers nicotine to the brain in roughly 10 to 20 seconds, because inhaled nicotine crosses the enormous surface area of the lungs almost instantly. Oral absorption is fundamentally slower. In clinical trials, peak nicotine blood levels from pouches typically arrive around 60 to 65 minutes after placement, compared to about 5 to 8 minutes for a cigarette.10PubMed Central. A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette That slower ramp-up is inherent to the mechanism: nicotine has to dissolve out of the product, diffuse across the tissue barrier, and enter small blood vessels, rather than riding an inhaled aerosol straight into the pulmonary circulation.
But the total amount of nicotine absorbed can be surprisingly high. A meta-analysis of trials comparing pouches to cigarettes found that lower-dose pouches (1.5 to 3.5 mg) produced lower peak blood levels than cigarettes, while higher-dose pouches approached or exceeded cigarette levels. Specifically, 4 mg pouches achieved about 69% of the peak nicotine concentration of a cigarette.11PubMed Central. Nicotine pouch pharmacokinetics compared to smoked tobacco: A systematic review and meta-analysis At the high end of the market, 30 mg nicotine pouches produced peak levels roughly double those of a cigarette in one study, reaching about 29 ng/mL versus 15 ng/mL for smoking.12PubMed Central. Small pouches, but high nicotine doses-nicotine delivery and acute effects after use of tobacco-free nicotine pouches And a 10 mg pouch delivered significantly greater peak concentration and total nicotine exposure than a cigarette over six hours.10PubMed Central. A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette So while the hit comes more gradually through the mouth, the ceiling is not necessarily lower.
How the Product Itself Controls Release
The oral mucosa is only half of the equation. Before nicotine can cross tissue, it first has to escape the product. Nicotine pouches, snus, chewing tobacco, and nicotine gum all use different matrices that dissolve at different rates, and these differences meaningfully affect how quickly and how much nicotine becomes available.
Among traditional smokeless tobacco products, American-style loose moist snuff releases nicotine fastest, with nearly all of its content dissolving within 30 minutes. Chopped loose-leaf chewing tobacco is close behind. Swedish-style snus in a pouch is considerably slower, still releasing nicotine after 60 minutes, with only about 63% released in the first 20 minutes compared to 99% for moist snuff.13Journal of Chromatography B. Method development and validation of dissolution testing for nicotine release from smokeless tobacco products using flow-through cell apparatus and UPLC-PDA Among modern tobacco-free pouches, brand-to-brand variation is also significant. Dissolution testing found that On!, Zyn, and Rogue released nicotine faster than Velo, Dryft, Volt, and Loop.14PubMed Central. Dissolution and physical characterization of oral nicotine pouch products
The filler material matters too. Pouches built around calcium sulphate granules delivered faster initial nicotine release and higher uptake compared to cellulose-based pouches like Zyn, partly because of higher local pH and partly because the nicotine salt dissolved more quickly.4Discover Medicine. Comparative study of calcium sulphate and cellulose based nicotine pouch on pharmacokinetics, pulse rate and nicotine extraction For users, this means that two pouches with identical nicotine content listed on the label can produce noticeably different experiences depending on how the product is engineered.
Nicotine Pouches Versus Gum and Lozenges
Nicotine replacement therapy products like gum and lozenges also rely on oral absorption, but they differ from pouches in how they deliver the drug. A randomized trial comparing a nicotine pouch, a nicotine lozenge, and nicotine gum head to head found that the pouch and lozenge produced similar peak blood levels (around 8.5 and 8.3 ng/mL, respectively) and similar total nicotine exposure over the measurement period. The gum came in substantially lower, with a peak of about 4.4 ng/mL and roughly half the total exposure of the pouch. Time to peak concentration was around 60 minutes for the pouch, 50 minutes for the gum, and 60 minutes for the lozenge, and all three products had a similar half-life of about 2.7 to 3 hours.6Nature. A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products
The gum’s lower delivery likely reflects a combination of factors. Chewing generates more saliva, which dilutes nicotine and encourages swallowing. Users who chew continuously rather than “parking” the gum against the cheek tend to swallow more nicotine, sending it through the liver’s first-pass metabolism rather than absorbing it buccally.7PubMed. Determinants of nicotine intake while chewing nicotine polacrilex gum A lozenge, by contrast, just sits in the mouth and dissolves gradually, behaving more like a pouch in terms of sustained mucosal contact.
What Happens to the Tissue Locally
While nicotine is being absorbed, it is also acting on the tissue it touches. One immediate effect is a change in blood flow. Placing snuff against the gum causes a rapid and significant increase in gingival blood flow at the exposed site, and to a lesser extent in the gum on the opposite side and even in forehead skin. This appears to happen because nicotine activates sensory nerves in the tissue, which then release vasodilatory peptides from their peripheral endings.15PubMed. The acute effects of smokeless tobacco (snuff) on gingival blood flow in man The increase in local blood flow could, in theory, speed absorption by carrying nicotine away from the tissue more quickly, maintaining a concentration gradient that favors continued diffusion.
With repeated use, the tissue where a pouch or snus is placed often develops visible changes. Case series have documented white, thickened lesions at the placement site, and biopsies of these lesions show characteristic changes: the outer layer of the lining thickens, fluid accumulates within the tissue, and chronic inflammatory cells appear.16PubMed Central. Oral mucosal changes caused by nicotine pouches: case series These changes are thought to be driven by oxidative stress and inflammatory signaling pathways triggered by nicotine and flavor additives in the products.17PubMed. Pathology of oral nicotine pouches and their addiction mechanisms One study that switched longtime snus users to tobacco-free nicotine pouches for several weeks found that existing mucosal lesions improved, with the proportion of participants showing pre-existing lesions at the placement site declining from 90% to 70%.18PubMed Central. The effect of a non-tobacco-based nicotine pouch on mucosal lesions caused by Swedish smokeless tobacco (snus) This suggests that some of the local tissue damage from snus may come from tobacco constituents rather than nicotine alone, though nicotine pouches still produce their own milder lesions.
Nicotine and Salivary Mucin
Your saliva is not just water. It contains mucins, large glycoproteins that form a protective film over the oral lining. Nicotine interacts with these mucins in ways that may influence how much drug reaches the tissue. Spectroscopic studies have confirmed that nicotine binds to salivary mucin, primarily through its pyrrolidyl ring, and the nature of the binding differs depending on pH: in acidic conditions the interaction is more transient, while in alkaline conditions it becomes more stable.19Journal of Spectroscopy. Probing into the Interaction of Nicotine and Bovine Submaxillary Mucin: NMR, Fluorescence, and FTIR Approaches Nicotine has also been shown to hinder the normal swelling and hydration of mucins after they are secreted, leading to higher mucus viscosity.20PubMed Central. Nicotine alters mucin rheological properties
The practical relevance here is that the mucin film acts as an additional diffusion layer between the product and the actual cell membranes. If nicotine binds to mucin before it reaches the tissue, some of it could be sequestered temporarily in the salivary film rather than crossing into blood vessels. This mucin reservoir may smooth out absorption over time, contributing to the slow, sustained nicotine delivery that characterizes oral products. The interaction is also pH-dependent, which adds another variable on top of the free-base chemistry described earlier.21Nicotine & Tobacco Research. The Role of TRP Channels in Nicotinic Provoked Pain and Irritation from the Oral Cavity and Throat
Why Absorption Varies from Person to Person
Even with the same product used in the same position, two people can absorb noticeably different amounts of nicotine. Modeling work attempting to predict nicotine pharmacokinetics from pouch products has identified several sources of this variability: individual differences in salivary flow rate, the buffering capacity of a person’s saliva, habitual oral movements during use, and exactly where in the mouth the pouch is placed all influence how much nicotine is released and how much of it actually crosses the mucosa.22Scientific Reports. Development of a model to predict nicotine pharmacokinetics from oral nicotine pouches Someone who produces a lot of saliva may dilute the local nicotine concentration and swallow more of it, reducing buccal absorption. Someone whose saliva is naturally more alkaline may absorb nicotine faster because conditions favor the free-base form.
Beyond saliva, the condition of the oral mucosa itself matters. Tissue that has thickened from chronic use (the hyperkeratotic lesions described earlier) presents a thicker barrier, potentially slowing absorption. Conversely, tissue that is inflamed or abraded may be more permeable. There is also metabolic variability: people differ in how quickly their livers clear nicotine once it is in the bloodstream, which affects how plasma levels build up over the course of using a product. Taken together, these factors mean that the neat pharmacokinetic curves from clinical studies represent group averages, and any individual’s experience can differ substantially.
The Role of Menthol and Flavorings
Most nicotine pouches and many forms of snus come in flavored versions, and menthol in particular is not merely a flavor. Nicotine on its own is a significant oral irritant with an aversive taste. Animal research has shown that menthol reduces this oral aversion through TRPM8, a receptor that senses cool temperatures and triggers analgesic and counterirritant mechanisms. When mice were exposed to a strongly aversive nicotine concentration, they preferred solutions that also contained menthol over nicotine alone.23BMJ Journals. Menthol decreases oral nicotine aversion in C57BL/6 mice through a TRPM8-dependent mechanism The cooling sensation masks the burn and bitterness, making it easier to keep a product in contact with the mucosa long enough for substantial absorption to occur. For a product that needs 30 to 60 minutes of contact time to deliver its nicotine payload, tolerability is not a trivial issue.
Periodontal and Microbiome Effects
Chronic nicotine exposure through the oral mucosa does not just change the tissue at the placement site. Nicotine interacts with receptors on immune cells, fibroblasts, and other cell types in the gums, affecting inflammatory responses, cellular repair processes, and the balance of reactive oxygen species.24PubMed Central. Emerging Oral Nicotine Products and Periodontal Diseases Over time, these effects can contribute to deterioration of the tissues that hold teeth in place.
There is also emerging evidence that oral nicotine pouch use shifts the composition of the salivary microbiome. Compared to non-users of tobacco, pouch users showed higher levels of certain bacterial genera and lower levels of others. The overall diversity of the microbial community was not dramatically different, but the spread of variation between individuals was narrower in the pouch-use group, suggesting that nicotine may impose a selective pressure that homogenizes the oral bacterial landscape to some degree.25PubMed Central. Oral Nicotine Pouch Use and Associations with Periodontal Status and Salivary Microbiome Dysbiosis What these shifts mean for long-term oral health remains unclear, but the finding that nicotine alone, without tobacco combustion products, can reshape the oral microbiome is worth noting.
Synthetic Versus Tobacco-Derived Nicotine
Many modern nicotine pouches market themselves as containing “tobacco-free nicotine,” which can mean either nicotine extracted from tobacco and then purified, or nicotine synthesized chemically without any tobacco plant involvement. The distinction matters chemically because tobacco-derived nicotine is almost entirely the S-isomer, which is the form that evolved to bind efficiently to nicotinic receptors. True synthetic nicotine is racemic, meaning it contains a roughly equal mix of S- and R-isomers. In an analysis of oral pouch products, only two brands (BRIDGE and FRĒ) actually contained racemic nicotine. The rest, despite some marketing tobacco-free nicotine, contained 100% S-nicotine, indicating they were using purified tobacco-derived nicotine rather than a fully synthetic product.26Nicotine & Tobacco Research. Comparison of Nicotine and Selected Flavoring Contents Between Tobacco-Free and Tobacco-Containing Oral Pouches
For absorption through the mouth, the isomer distinction is unlikely to make a large difference in the basic permeation process, since the physical chemistry of crossing membranes is similar for both forms. But the R-isomer binds less effectively to nicotinic receptors, so racemic products could theoretically deliver a somewhat different pharmacological punch per milligram of total nicotine. Whether users can perceive this difference in practice has not been thoroughly studied, but it is another variable hiding behind what looks like a simple label.